Logo-jnp
Meta-analysis

1. Association between SGLT2 (sodium-glucose cotransporter-2) inhibitors and bladder cancer in individuals with type 2 diabetes; a systematic review and meta-analysis
Mobin Mohammadtabar ORCID, Alireza Fazeli ORCID, Najmeh Parsai ORCID, Zahra Aboulfathiyarmohammadyar ORCID, Erfan Shafiei ORCID, Mohamad Khaledi ORCID, Elahe Zaremoghadam ORCID, Ali Rahnama Sisakht ORCID, Saeid Mohammadi ORCID, Hossein Mardanparvar* ORCID
J Nephropathol. 2023;12(2): e21444. doi: 10.34172/jnp.2023.21444
Scopus ID: 85151333510    
Article
PDF
XML
Cited By:
0
0
Meta-analysis

2. Dapagliflozin in patients with chronic kidney disease: a systematic review and meta-analysis on randomized, double-blind, placebo-controlled multicenter trials
Hamidreza Khodabandeh ORCID, Hanieh Molaee ORCID, Ladan Ghashghaie ORCID, Mohammad Reza Farnia ORCID, Soleyman Alivand ORCID, Faraz Zandiyeh ORCID, Farshad Gharebakhshi ORCID, Elham Rashidi ORCID, Nahid Mir* ORCID
J Nephropathol. 2025;. doi: 10.34172/jnp.2023.21472
Article
PDF
XML
Cited By:
0
Meta-analysis

3. Administration of sodium-glucose cotransporter-2 inhibitors in kidney transplant patients with diabetes: a systematic review and meta-analysis
Hamidreza Khodabandeh ORCID, Zahra Bakhshizade ORCID, Mohammad Hossein Taklif ORCID, Halime Zaeri Fakhrabadi ORCID, Soleyman Alivand ORCID, Noorbakhsh Alivand ORCID, Ghazaleh Rashidizadeh ORCID, Leila Jampour ORCID, Mahsa Shirani* ORCID
J Nephropathol. 2023;12(4): e21477. doi: 10.34172/jnp.2023.21477
Scopus ID: 85172673483    
Article
PDF
XML
Cited By:
0
0